Innovations of 2020: A Look Back at Key Innovations That Were Developed During the COVID-19 Pandemic
The scientific community starred in the development of several innovations designed to overcome the healthcare challenges brought on by the COVID-19 pandemic.
CMS Updates CLIA FAQ Guidance for Clinical Laboratories
Guidance changed for three questions about CLIA standards pertaining to COVID-19 testing.
New Study Searches for a Better Face Mask by Examining How Face Shape Affects Fit
While face masks are thought to play an important role in mitigating the epidemiological risks of COVID-19, new research aims to understand how well various types of cloth masks and even “nonmedical” surgical masks work.
New EUA Makes COVID-19 Testing Available for Patients Without Clinical Laboratories Playing a Role
First EUA for at-home and over-the-counter COVID-19 testing removes the need for clinical laboratories to perform COVID-19 diagnostic testing.
FDA Issues EUA for Third At-Home COVID-19 Test to Abbott
The FDA continues to accelerate at-home COVID-19 test accessibility for consumers with this, the third emergency use authorization for a fully at-home test.
CMS Releases Medicare Accelerated and Advance Payments Program Data
Insight into the federal payments that clinical laboratories received after CMS expanded its Accelerated and Advance Payment (AAP) Program to increase cash flow to Medicare providers and suppliers impacted by the 2019 novel coronavirus (COVID-19) public health emergency.
Clinical Laboratories May See Unexpectedly Low Number of Influenza Cases This Flu Season
Week-by-week flu surveillance data show influenza testing in clinical laboratories compared to public health laboratories. While flu cases may be down, testing appears up.
NIH Research Program Leads to Creation of Online Calculator for Determining the Costs of Organizational COVID-19 Testing
The COVID-19 testing calculator tool developed by NIBIB is a mathematical model-based calculator that produces customized scenarios for COVID-19 surveillance testing.
FDA Issues EUA for First-Ever Direct-to-Consumer COVID-19 Test, Moving COVID-19 Further From Clinical Laboratories
While the availability of a nonprescription, at-home COVID-19 test collection kit will certainly increase the ease with which testing can be obtained, this new EUA seems to benefit LabCorp exclusively.
CMS Releases Answers to FAQ for COVID-19 Testing in Nursing Homes
Explanation of the range of new guidance for approaching COVID-19 testing in nursing homes.